Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines
The company behind the slimming jab Wegovy has been suspended from the UK’s pharmaceutical trade association after a row over sponsored weight-loss courses that promoted its medicines.
The Association of the British Pharmaceutical Industry (ABPI) said an extensive investigation by the Prescription Medicines Code of Practice Authority (PMCPA) found Novo Nordisk to be in breach of the ABPI code of practice.
